Baricitinib

Baricitinib is an orally bioavailable inhibitor of Janus kinases 1 and 2 (JAK1/2), with potential anti-inflammatory, immunomodulating and antineoplastic activities.

Price Not Available 25 mg Baricitinib Supplier Page

Catalog Number	T2485
Alternative Name(s)	INCB028050 , LY3009104
Research Area	Tyrosine Kinase/Adaptors\|\|\|Chromatin/Epigenetic\|\|\|JAK/STAT signaling\|\|\|Stem Cells\|\|\|Angiogenesis\|\|\|Cell Cycle/Checkpoint
Molecular Formula	C16H17N7O2S
CAS#	1187594-09-7
SMILES	CCS(=O)(=O)N1CC(C1)(CC#N)n1cc(cn1)c1c2cc[nH]c2ncn1
Size	25 mg
Supplier Page	https://www.targetmol.com/compound/Baricitinib
Additional Information	https://www.targetmol.com/datasheet/T2485